Projects per year
Organization profile
Organisation profile
The Microbiology Research Group is comprised of three research units conducting fundamental and translational biomedical research to enhance the control of diseases caused by:
- Mycobacterium tuberculosis, M. leprae, and M. ulcerans (Mycobacteriology Unit)
- Arboviruses (Virology Unit and Experimental Immunology Unit)
The group shares common research questions, expertise and technologies in fundamental and translational biomedical research to improve the diagnosis, treatment and surveillance of mycobacteria and viruses in global public health concern, as well as to understand immunity against these pathogens and exploit it for new treatments and vaccines.
Fingerprint
Dive into the research topics where Microbiology Research Group is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Implementation and evaluation of new tools for Ebola Virus Disease response during eastern Democratic Republic of Congo outbreaks: from rapid diagnostic tests to genomic sequencing
Mukadi, D. B., van Griensven, J., Ariën, K., Ariën, K. & Ahuka, S. M.
1/07/22 → …
Project: PhD-project
-
Omics Data Integration to Predict Drug Resistance in Mycobacterium tuberculosis
Snobre, J., de Jong, B. & Buyl, R.
27/04/22 → …
Project: PhD-project
-
Rapid diagnosis of Mycobacterium tuberculosis resistance, beyond rifampicin
Massou, F. A. T., de Jong, B., Rigouts, L., Affolabi, D. & Meehan, C. J.
1/01/22 → …
Project: PhD-project
Research output
-
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
Van Deun, A., Bola, V., Lebeke, R., Kaswa, M., Hossain, M. A., Gumusboga, M., Torrea, G., De Jong, B. C., Rigouts, L. & Decroo, T., 2022, In: JAC-Antimicrobial Resistance. 4, 2, 9 p., dlac037.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell mediated immunity
McCafferty, S., Haque, A. A., Vandierendonck, A., Weidensee, B., Plovyt, M., Stuchlíková, M., François, N., Valembois, S., Heyndrickx, L., Michiels, J., Ariën, K. K., Vandekerckhove, L., Abdelnabi, R., Foo, C. S., Neyts, J., Sahu, I. & Sanders, N. N., 2022, In: Molecular Therapy. 30, 9, p. 2968-2983 16 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
-
A high-throughput yellow fever neutralization assay
Rasulova, M., Vercruysse, T., Paulissen, J., Coun, C., Suin, V., Heyndrickx, L., Ma, J., Geerts, K., Timmermans, J., Mishra, N., Li, L-H., Kum, D. B., Coelmont, L., Van Gucht, S., Karimzadeh, H., Thorn-Seshold, J., Rothenfußer, S., Ariën, K. K., Neyts, J., Dallmeier, K. & 1 others, , 2022, In: Microbiology Spectrum. 10, 3, 11 p., e0254821.Research output: Contribution to journal › A1: Web of Science-article › peer-review